157 related articles for article (PubMed ID: 23077460)
1. Contrasting effect of recombinant human erythropoietin on breast cancer cell response to cisplatin induced cytotoxicity.
Trost N; Juvan P; Sersa G; Debeljak N
Radiol Oncol; 2012 Sep; 46(3):213-25. PubMed ID: 23077460
[TBL] [Abstract][Full Text] [Related]
2. Recombinant human erythropoietin alters gene expression and stimulates proliferation of MCF-7 breast cancer cells.
Trost N; Stepisnik T; Berne S; Pucer A; Petan T; Komel R; Debeljak N
Radiol Oncol; 2013; 47(4):382-9. PubMed ID: 24294184
[TBL] [Abstract][Full Text] [Related]
3. Growth and molecular interactions of the anti-EGFR antibody cetuximab and the DNA cross-linking agent cisplatin in gefitinib-resistant MDA-MB-468 cells: new prospects in the treatment of triple-negative/basal-like breast cancer.
Oliveras-Ferraros C; Vazquez-Martin A; López-Bonet E; Martín-Castillo B; Del Barco S; Brunet J; Menendez JA
Int J Oncol; 2008 Dec; 33(6):1165-76. PubMed ID: 19020749
[TBL] [Abstract][Full Text] [Related]
4. Recombinant epoetins do not stimulate tumor growth in erythropoietin receptor-positive breast carcinoma models.
LaMontagne KR; Butler J; Marshall DJ; Tullai J; Gechtman Z; Hall C; Meshaw A; Farrell FX
Mol Cancer Ther; 2006 Feb; 5(2):347-55. PubMed ID: 16505108
[TBL] [Abstract][Full Text] [Related]
5. Recombinant human erythropoietin treatment for chemotherapy-related anemia in children.
Varan A; Büyükpamukçu M; Kutluk T; Akyüz C
Pediatrics; 1999 Feb; 103(2):E16. PubMed ID: 9925862
[TBL] [Abstract][Full Text] [Related]
6. Recombinant human erythropoietin in combination with chemotherapy increases breast cancer metastasis in preclinical mouse models.
Hedley BD; Chu JE; Ormond DG; Beausoleil MS; Boasie A; Allan AL; Xenocostas A
Clin Cancer Res; 2011 Oct; 17(19):6151-62. PubMed ID: 21856770
[TBL] [Abstract][Full Text] [Related]
7. Mir-1307 regulates cisplatin resistance by targeting Mdm4 in breast cancer expressing wild type P53.
Wang X; Zhu J
Thorac Cancer; 2018 Jun; 9(6):676-683. PubMed ID: 29697201
[TBL] [Abstract][Full Text] [Related]
8. Recombinant Human erythropoietin reduces viability of MCF-7 breast cancer cells from 3D culture without caspase activation.
ShujaaEdin HY; Al-Haj NA; Rasedee A; Alitheen NB; Kadir AA; How CW; Rahman HS; Abdullah AH
Saudi J Biol Sci; 2021 Apr; 28(4):2549-2557. PubMed ID: 33935571
[TBL] [Abstract][Full Text] [Related]
9. Novel signaling molecules implicated in tumor-associated fatty acid synthase-dependent breast cancer cell proliferation and survival: Role of exogenous dietary fatty acids, p53-p21WAF1/CIP1, ERK1/2 MAPK, p27KIP1, BRCA1, and NF-kappaB.
Menendez JA; Mehmi I; Atlas E; Colomer R; Lupu R
Int J Oncol; 2004 Mar; 24(3):591-608. PubMed ID: 14767544
[TBL] [Abstract][Full Text] [Related]
10. Effect of fetal bovine serum on erythropoietin receptor expression and viability of breast cancer cells.
Teo GY; Rasedee A; Al-Haj NA; Beh CY; How CW; Rahman HS; Alitheen NB; Rosli R; Abdullah AH; Ali AS
Saudi J Biol Sci; 2020 Feb; 27(2):653-658. PubMed ID: 32210684
[TBL] [Abstract][Full Text] [Related]
11. Recombinant human Erythropoietin enhanced the cytotoxic effects of tamoxifen toward the spheroid MCF-7 breast cancer cells.
Shujaa Edin HY; Al-Haj NA; Rasedee A; Banu Alitheen N; Abdul Kadir A; Wun How C; Sulaiman Rahman H; Al-Shwyeh HA
Saudi J Biol Sci; 2021 Sep; 28(9):5214-5220. PubMed ID: 34466099
[TBL] [Abstract][Full Text] [Related]
12. Induction of p53 Phosphorylation at Serine 20 by Resveratrol Is Required to Activate p53 Target Genes, Restoring Apoptosis in MCF-7 Cells Resistant to Cisplatin.
Hernandez-Valencia J; Garcia-Villa E; Arenas-Hernandez A; Garcia-Mena J; Diaz-Chavez J; Gariglio P
Nutrients; 2018 Aug; 10(9):. PubMed ID: 30142917
[TBL] [Abstract][Full Text] [Related]
13. Recombinant erythropoietin differently affects proliferation of mesothelioma cells but not sensitivity to cisplatin and pemetrexed.
Palumbo C; Battisti S; Carbone D; Albonici L; Alimandi M; Bei R; Modesti A
Cancer Chemother Pharmacol; 2008 Apr; 61(5):893-901. PubMed ID: 17922127
[TBL] [Abstract][Full Text] [Related]
14. Erythropoietin against cisplatin-induced peripheral neurotoxicity in rats.
Orhan B; Yalcin S; Nurlu G; Zeybek D; Muftuoglu S
Med Oncol; 2004; 21(2):197-203. PubMed ID: 15299192
[TBL] [Abstract][Full Text] [Related]
15. Correlation between erythropoietin receptor(s) and estrogen and progesterone receptor expression in different breast cancer cell lines.
Trošt N; Hevir N; Rižner TL; Debeljak N
Int J Mol Med; 2013 Mar; 31(3):717-25. PubMed ID: 23314808
[TBL] [Abstract][Full Text] [Related]
16. Recombinant human erythropoietin treatment in elderly cancer patients with cisplatin-associated anemia.
Cascinu S; Del Ferro E; Fedeli A; Ligi M; Alessandroni P; Catalano G
Oncology; 1995; 52(5):422-6. PubMed ID: 7637961
[TBL] [Abstract][Full Text] [Related]
17. Activity and expression of progesterone metabolizing 5alpha-reductase, 20alpha-hydroxysteroid oxidoreductase and 3alpha(beta)-hydroxysteroid oxidoreductases in tumorigenic (MCF-7, MDA-MB-231, T-47D) and nontumorigenic (MCF-10A) human breast cancer cells.
Wiebe JP; Lewis MJ
BMC Cancer; 2003 Mar; 3():9. PubMed ID: 12659654
[TBL] [Abstract][Full Text] [Related]
18. Antiapoptotic properties of erythropoiesis-stimulating proteins in models of cisplatin-induced acute kidney injury.
Salahudeen AK; Haider N; Jenkins J; Joshi M; Patel H; Huang H; Yang M; Zhe H
Am J Physiol Renal Physiol; 2008 Jun; 294(6):F1354-65. PubMed ID: 18385271
[TBL] [Abstract][Full Text] [Related]
19. Assessment of Interactions between Cisplatin and Two Histone Deacetylase Inhibitors in MCF7, T47D and MDA-MB-231 Human Breast Cancer Cell Lines - An Isobolographic Analysis.
Wawruszak A; Luszczki JJ; Grabarska A; Gumbarewicz E; Dmoszynska-Graniczka M; Polberg K; Stepulak A
PLoS One; 2015; 10(11):e0143013. PubMed ID: 26580554
[TBL] [Abstract][Full Text] [Related]
20. Disruption of p53 function sensitizes breast cancer MCF-7 cells to cisplatin and pentoxifylline.
Fan S; Smith ML; Rivet DJ; Duba D; Zhan Q; Kohn KW; Fornace AJ; O'Connor PM
Cancer Res; 1995 Apr; 55(8):1649-54. PubMed ID: 7712469
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
